• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.02% Nasdaq Down 0.07%

    Arbutus Biopharma Corporation (ABUS)

    -NasdaqGS
    3.15 0.00(0.00%) 4:00PM EDT
    Prev Close:3.15
    Open:3.10
    Bid:2.80 x 2500
    Ask:3.65 x 400
    1y Target Est:7.46
    Beta:1.4218
    Earnings Date:May 2 - May 8 (Est.)
    Day's Range:3.10 - 3.20
    52wk Range:2.35 - 5.48
    Volume:88,084
    Avg Vol (3m):274,295
    Market Cap:172.75M
    P/E (ttm):N/A
    EPS (ttm):-3.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ABUS

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.02
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-3.68
    Quarterly EPS Est (Dec-16) :-0.38
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arbutus Biopharma Corporation, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of chronic hepatitis B (HBV) infections in Canada and the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback